These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29085688)

  • 1. Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma.
    Kasahara R; Nakaigawa N; Kobayashi K
    Case Rep Oncol Med; 2017; 2017():2648471. PubMed ID: 29085688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib rechallenge in patients with metastatic renal cell carcinoma.
    Nozawa M; Yamamoto Y; Minami T; Shimizu N; Hatanaka Y; Tsuji H; Uemura H
    BJU Int; 2012 Sep; 110(6 Pt B):E228-34. PubMed ID: 22332735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising response to axitinib rechallenge for metastatic renal cell carcinoma after progression on prior axitinib: report of two cases.
    Miyake H; Harada KI; Fujisawa M
    Int Cancer Conf J; 2018 Jan; 7(1):30-34. PubMed ID: 31149509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma.
    Fujiwara M; Shimada W; Yokoyama M; Koyanagi A; Shintaku H; Fukuda S; Waseda Y; Tanaka H; Yoshida S; Fujii Y
    IJU Case Rep; 2024 Jul; 7(4):293-296. PubMed ID: 38966764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].
    Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N
    Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged survival after sequential multimodal treatment in metastatic renal cell carcinoma: two case reports and a review of the literature.
    Syrios J; Kechagias G; Tsavaris N
    J Med Case Rep; 2012 Sep; 6():303. PubMed ID: 22978809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report.
    Murata M; Ikeda Y; Hasegawa G; Nakagawa Y; Nishiyama T
    J Med Case Rep; 2019 Apr; 13(1):98. PubMed ID: 31006385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug].
    Kobayashi H; Ashikari A; Namitome R; Yagi Y; Kohno Y; Nishiyama T; Saito S
    Nihon Hinyokika Gakkai Zasshi; 2012 Sep; 103(5):660-4. PubMed ID: 23342925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma.
    Takinami M; Yokota T
    Case Rep Oncol; 2020; 13(2):522-527. PubMed ID: 32518548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report.
    Ueda K; Suekane S; Ogasawara N; Chikui K; Suyama S; Nakiri M; Nishihara K; Matsuo M; Igawa T
    J Med Case Rep; 2016 Jun; 10():177. PubMed ID: 27312478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of metastatic renal cell carcinoma with no evidence of disease for a long term after a favorable response to molecular-targeted therapy followed by metastasectomy].
    Ikehata Y; Takahashi S; Kitamura H; Masumori N; Tsukamoto T
    Hinyokika Kiyo; 2013 Jun; 59(6):369-72. PubMed ID: 23827870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib.
    Morinaga R; Kawahara T; Teranishi JI; Chuma M; Izumi K; Miyoshi Y; Yao M; Otani M; Miyamoto H; Uemura H
    IJU Case Rep; 2019 Jan; 2(1):43-46. PubMed ID: 32743370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma-Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study.
    Oudard S; Geoffrois L; Guillot A; Chevreau C; Deville JL; Falkowski S; Boyle H; Baciuchka M; Gimel P; Laguerre B; Laramas M; Pfister C; Topart D; Rolland F; Legouffe E; Denechere G; Amela EY; Abadie-Lacourtoisie S; Gross-Goupil M
    Eur J Cancer; 2016 Jul; 62():28-35. PubMed ID: 27192659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report.
    Wendel C; Campitiello M; Plastino F; Eid N; Hennequin L; Quétin P; Longo R
    Am J Case Rep; 2017 Jan; 18():7-11. PubMed ID: 28044054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disease control of metastatic type 2 papillary renal cell carcinoma using local treatment and molecular targeted therapy: A case report.
    Arai Y; Kitamura Y; Miyai K; Hatanaka M; Hashimoto H; Horiguchi A; Ito K
    Mol Clin Oncol; 2021 Apr; 14(4):71. PubMed ID: 33732457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
    Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
    BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vertebral cryoablation and immunotherapy in a patient with metastatic renal cell carcinoma: a case report.
    Sangsin A; Murakami H; Shimizu T; Kato S; Tsuchiya H
    J Med Case Rep; 2019 Apr; 13(1):96. PubMed ID: 31005126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
    Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
    Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization of liver metastasis from renal cell carcinoma.
    Matsuda H; Tamada S; Kato M; Yamamoto A; Iguchi T; Nakatani T
    Urol Case Rep; 2018 Mar; 17():79-81. PubMed ID: 29541587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.